Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Brain Neoplasms 9Carcinoma, Non-Small-Cell Lung 5Recurrence 3Neoplasms 3Neoplasm Metastasis 2Melanoma 2Glioblastoma 2Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Obesity 1Neuroblastoma 1Motor Activity 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Hepatitis 1Health Behavior 1Gliosarcoma 1Glioma 1Fibrosis 1Cognition Disorders 1Child Behavior 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Behavior 1

Interventions

Mycophenolic Acid 2Blood Specimen Collection 2vedolizumab 1bavituximab 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Steroids 1Spermine Synthase 1Sorafenib 1Sofosbuvir 1Ribavirin 1Prednisone 1Photopheresis 1Phlebotomy 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methoxsalen 1Liquid Biopsy 1Infliximab 1Clinical Protocols 1Azathioprine 1Adrenal Cortex Hormones 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis × Spermine Synthase × Clear all
NCT05429190 2023-11-29

Validation of SMS Protocol for HCC Screening in High-risk Patients

Erasmus Medical Center

Unknown
470 enrolled
Gastrointestinal

Fibrosis, Hepatitis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡